Bulls N' Bears with Matt Birney

By: Bulls N' Bears on 6PR Radio
Listen for free

  • Summary

  • Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.
    Show More Show Less
Economics Personal Finance
Show More Show Less
activate_samplebutton_t1
Episodes
  • Lithium Australia: Sure beats mining it – sucking millions in lithium and nickel out of old lithium batteries

    Lithium Australia: Sure beats mining it – sucking millions in lithium and nickel out of old lithium batteries
    Oct 18 2024

    Lithium Australia: Sure beats mining it – sucking millions in lithium and nickel out of old lithium batteries

    Listen to ASX-listed Lithium Australia Managing Director Simon Linge talk to Matt Birney on the Bulls N’ Bears Report about Lithium Australia’s lithium battery recycling division that has hit its straps with a record quarterly profit derived from sucking lithium and nickel out of old lithium batteries.

    See omnystudio.com/listener for privacy information.
    Show More Show Less
    2 mins
  • Kali Metals: Why are mega-miners like Min Res and SQM hanging around this ASX junior?

    Kali Metals: Why are mega-miners like Min Res and SQM hanging around this ASX junior?
    Oct 17 2024

    Kali Metals: Why are mega-miners like Min Res and SQM hanging around this ASX junior?

    Listen to ASX-listed Kali Metals Managing Director Paul Adams talk to Matt Birney on the Bulls N’ Bears Report about Kali’s multimillion-dollar WA farm in deal with one of the biggest lithium miners on the planet.

    See omnystudio.com/listener for privacy information.
    Show More Show Less
    3 mins
  • Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

    Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?
    Oct 17 2024

    Clarity Pharmaceuticals: From $1 to $9 a share - Could this eventually be a cure for prostate cancer?

    Listen to ASX-listed Clarity Pharmaceuticals Executive Chair Alan Taylor talk to Matt Birney on the Bulls N’ Bears Report about Clarity’s amazing clinical trial results that saw a complete response in one patient and lots with a 90 per cent plus reduction in signs of prostate cancer using “copper” based radiopharmaceuticals.

    See omnystudio.com/listener for privacy information.
    Show More Show Less
    3 mins

What listeners say about Bulls N' Bears with Matt Birney

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.